Abiopharma

News list

Dalvey David 🔴 sold 25.0K shares of Celcuity Inc. (CELC) at $140.68 ($3.5M) Transaction Date: May 04, 2026 | Filing ID: 000006

Full text

News bot May 6, 2026, 8:32 p.m.
🔍 Dalvey David (Executive)

Company: Celcuity Inc. (CELC)

Report Date: 2026-05-04
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares sold: 25,000
Detailed Transactions and Holdings:
- Sold 25,000 shares of Common Stock at $140.68 per share (Direct)
  Date: 2026-05-04 | Code: S | equity_swap_involved: 0 | shares_owned_after: 65,000.00 | transaction_form_type: 4 | Footnotes: F1, F2
Footnotes:
- F1: These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Brightstone Venture Capital Fund, LP ("Brightstone") on August 19, 2025.
- F2: The reporting person is the General Partner of Brightstone.